Literature DB >> 20579135

Varicocele correction for infertility: which patients to treat?

V A Giagulli1, M D Carbone.   

Abstract

Given the lack of clarity regarding the value of varicocele correction in improving male fertility, we examined whether divergent results in this regard could be attributed to selection of patients, especially with regard to the duration of their infertility or to the length of patients' androgen receptor CAG repeats. In a prospective study, involving all varicocele patients consulted consecutively for infertility, we compared the pregnancy rate (PR) over 1 year produced by patients who opted not to have varicocele correction after extensive information concerning fertility prospects (N = 185), with that by patients who had varicocele correction (N = 137). In the second study involving another smaller group of varicocele subjects (N = 72), we investigated whether CAG repeat length in the androgen receptor gene had any influence on fertility of varicocele-corrected patients. Overall, the PR in corrected and uncorrected varicocele groups did not differ significantly, but when subjects with infertility beyond 2 years were considered, varicocele-corrected subjects had a significantly greater PR than uncorrected varicocele patients (p = 0.025). Together with infertility duration, spermatozoa progressive motility appears the most important predictor of fertility, whereas neither grade of varicocele nor age of the couple (within the age limits of this study) influenced the outcome. Similarly, CAG repeat length did not affect the outcome of varicocele correction. These data suggest that varicocele correction at 1 year of infertility does not result in a significantly higher PR than that achieved by men with uncorrected varicocele. In view of the high spontaneous PR in subjects with an infertility of less than 2 years, varicocele correction aimed at restoring fertility appears to be most appropriate for men whose infertility extends beyond 2 years.
© 2010 The Authors. International Journal of Andrology © 2011 European Academy of Andrology.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20579135     DOI: 10.1111/j.1365-2605.2010.01081.x

Source DB:  PubMed          Journal:  Int J Androl        ISSN: 0105-6263


  7 in total

Review 1.  Treating varicocele in 2018: current knowledge and treatment options.

Authors:  M Zavattaro; C Ceruti; G Motta; S Allasia; L Marinelli; C Di Bisceglie; M P Tagliabue; M Sibona; L Rolle; F Lanfranco
Journal:  J Endocrinol Invest       Date:  2018-10-03       Impact factor: 4.256

Review 2.  The benefits of varicocele repair for achieving pregnancy in male infertility: A systematic review and meta-analysis.

Authors:  Ponco Birowo; William Tendi; Indah Suci Widyahening; Widi Atmoko; Nur Rasyid
Journal:  Heliyon       Date:  2020-11-05

3.  Could androgen receptor gene CAG tract polymorphism affect spermatogenesis in men with idiopathic infertility?

Authors:  V A Giagulli; M D Carbone; G De Pergola; E Guastamacchia; F Resta; B Licchelli; C Sabbà; V Triggiani
Journal:  J Assist Reprod Genet       Date:  2014-04-02       Impact factor: 3.412

Review 4.  Traditional Chinese Herb Combined with Surgery versus Surgery for Varicocele Infertility: A Systematic Review and Meta-Analysis.

Authors:  Rong-Liang Dun; Min Yao; Long Yang; Xue-Jun Cui; Jian-Min Mao; Yu Peng; Guang-Chong Qi
Journal:  Evid Based Complement Alternat Med       Date:  2015-01-29       Impact factor: 2.629

5.  The role of flaxseed and vitamin E on oxidative stress in prepubertal rats with experimental varicocele: An experimental study.

Authors:  Shahla Sohrabipour; Adele Jafari; Mohamad Kamalinejad; Abdolfatah Sarrafnejd; Taherah Shahrestany; Hamid-Reza Sadeghipour
Journal:  Iran J Reprod Med       Date:  2013-06

Review 6.  Summary evidence on the effects of varicocele treatment to improve natural fertility in subfertile men.

Authors:  Bruno C Tiseo; Sandro C Esteves; Marcello S Cocuzza
Journal:  Asian J Androl       Date:  2016 Mar-Apr       Impact factor: 3.285

7.  Clomiphene citrate effect in obese men with low serum testosterone treated with metformin due to dysmetabolic disorders: A randomized, double-blind, placebo-controlled study.

Authors:  Carla Pelusi; Vito Angelo Giagulli; Margherita Baccini; Flaminia Fanelli; Marco Mezzullo; Alessia Fazzini; Nicola Bianchi; Matteo Domenico Carbone; Giovanni De Pergola; Marianna Mastroroberto; Antonio Maria Morselli Labate; Renato Pasquali
Journal:  PLoS One       Date:  2017-09-08       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.